Journal
CLINICAL SCIENCE
Volume 136, Issue 1, Pages 45-60Publisher
PORTLAND PRESS LTD
DOI: 10.1042/CS20210823
Keywords
-
Categories
Funding
- Merit Review Award from the Department of Veterans Affairs of USA [I01 BX000319]
- National Institutes of Health of USA [5R01DK058831, 5R01DK087843]
- Senior Research Career Scientist award from the Department of Veterans Affairs of USA
Ask authors/readers for more resources
This study reveals the pathogenic role of HDAC3 in cold storage/rewarming injury in kidney transplantation. Selective inhibition of HDAC3 can reduce acute tubular injury and cell death after prolonged cold storage, and improve renal function and tubular integrity. In vitro experiments also show that HDAC3 inhibition can suppress cell death induced by cold storage and rewarming of proximal tubular cells.
Cold storage/rewarming is an inevitable process for kidney transplantation from deceased donors, which correlates closely with renal ischemia-reperfusion injury (IRI) and the occurrence of delayed graft function. Histone deacetylases (HDAC) are important epigenetic regulators, but their involvement in cold storage/rewarming injury in kidney transplantation is unclear. In the present study, we showed a dynamic change of HDAC3 in a mouse model of kidney cold storage followed by transplantation. We then demonstrated that the selective HDAC3 inhibitor RGFP966 could reduce acute tubular injury and cell death after prolonged cold storage with transplantation. RGFP966 also improved renal function, kidney repair and tubular integrity when the transplanted kidney became the sole life-supporting graft in the recipient mouse. In vitro, cold storage of proximal tubular cells followed by rewarming induced remarkable cell death, which was suppressed by RGFP966 or knockdown of HDAC3 with shRNA. Inhibition of HDAC3 decreased the mitochondrial pathway of apoptosis and preserved mitochondrial membrane potential. Collectively, HDAC3 plays a pathogenic role in cold storage/rewarming injury in kidney transplantation, and its inhibition may be a therapeutic option.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available